| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |